Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV | NASDAQ
Chart Builder DCF Calculator
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.29
$0.00 (+0.01%)
After-hours: Nov 5, 2026, 5:41 PM ET
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Cash & Equivalents
5.52M n/a 2.01M 4.2M 1.89M 2.05M 3.3M 2.77M 3.75M 2.03M 926K 1.97M 3.46M 13.14M 47.82M 38.55M 20.15M 67.67M 11.2M 22.15M 12.61M 4.09M
Short-Term Investments
n/a n/a 3.86M 14.12M 17.62M 18.5M 20.2M 21.73M 22.2M 21.52M 26.51M 28.53M 25.44M 22.84M 299K n/a 42.33M 10.34M 72.93M 65.48M 77.99M 87.58M
Long-Term Investments
407K n/a 374K 359K n/a n/a 531K 826K 1.21M 319K 308K n/a 7.45M 7.55M n/a 283K n/a n/a 3K 307K 88K 86K
Other Long-Term Assets
1.5M n/a n/a n/a 351K 319K 10K 89K 92K 110K 179K 796K 485K 104K 412K 139K 404K 448K 482K 6K 6K 5K
Receivables
25K n/a 235K 567K 890K 1.13M 1.3M 1.29M 1.15M 3.7M 229K 1.34M 1.88M 1.6M 647K 1.46M 2.45M 1.18M 1.09M 1.78M 1.35M 885K
Inventory
n/a n/a n/a n/a n/a n/a n/a 113K 113K n/a -229K n/a n/a n/a 1.18M n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.74B -5.76M 1.73B 85K 238K 217K 198K 228K 228K 229K 5.34M n/a n/a n/a -1.18M -1.35M 113K 113K 1.23M 874K 883K 340K
Total Current Assets
3.75B n/a 1.74B 19.5M 21.32M 22.65M 25.99M 27.11M 28.57M 28.38M 33.76M 31.84M 30.79M 37.58M 52.33M 59.23M 65.05M 79.3M 86.44M 90.28M 92.83M 93.78M
Property-Plant & Equipment
249K n/a 938K 1.08M 923K 1.07M 1.15M 1.77M 2.03M 2.24M 2.58M 14.3M 14.31M 14.79M 14.9M 12.76M 11.89M 8.87M 8.22M 7.57M 2.27M 2.1M
Goodwill & Intangibles
1.15B n/a 582.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.15B n/a 583.82M 1.44M 1.27M 1.39M 1.69M 2.69M 3.33M 2.67M 3.07M 15.1M 22.24M 22.44M 15.31M 13.18M 12.29M 9.32M 8.7M 7.89M 2.36M 2.19M
Total Assets
4.9B n/a 2.33B 20.94M 22.6M 24.04M 27.69M 29.8M 31.9M 31.05M 36.83M 46.94M 53.03M 60.02M 67.64M 72.41M 77.34M 88.62M 95.15M 98.17M 95.19M 95.96M
Account Payables
1.69M n/a 3.81M 375K 542K 533K 811K 92K 303K 643K 827K 794K 1.55M 1.48M 1.95M 1.06M 667K 1.36M 878K 1.06M 558K 347K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
16.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
128K n/a 1.89M 602K 1.46M 1.41M 142K 301K 291K n/a 1.23M 372K 1.07M 1.35M n/a 113K 113K 113K n/a 792K 793K 1.15M
Total Current Liabilities
31.42M n/a 9.02M 3.03M 3.33M 3.14M 3.8M 2.79M 2.84M 3.61M 6.06M 4.34M 4.99M 5.45M 6.61M 4.53M 4.21M 5.74M 4.72M 4.73M 4.58M 4.91M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.61M n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a -1.93B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.61M n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
970.31M -1.93B 383.03M 426K 216K 264K 299K 419K 499K 587K 686K 3.82M 3.7M 4M 4.19M 4.61M 4.64M 5.23M 5.39M 5.35M 405K 449K
Total Liabilities
1B -1.93B 392.05M 3.46M 3.54M 3.41M 4.1M 3.21M 3.34M 4.2M 6.75M 8.16M 8.69M 9.45M 10.8M 9.14M 8.86M 10.97M 10.11M 10.08M 4.98M 5.36M
Total Debt
17.25M n/a 641K 701K 480K 503K 534K 765K 835K 928K 1.03M 4.52M 4.37M 4.68M 4.85M 5.26M 5.27M 5.92M 6.01M 5.99M 615K 654K
Book Value
3.9B 1.93B 1.93B 17.48M 19.05M 20.63M 23.59M 26.59M 28.56M 26.85M 30.08M 38.78M 44.34M 50.57M 56.84M 63.27M 68.49M 77.65M 85.04M 88.08M 90.21M 90.61M
Book Value Per Share
3.23K 1.72K 9.63K 174.48 191.69 226.10 258.57 299.88 350.72 344.12 388.21 500.45 572.53 655.51 740.52 825.68 894.51 1.01K 1.11K 1.15K 1.18K 1.32K
Common Stock
30.7M n/a 28.73M 2.76M 2.71M 2.71M 2.69M 2.5M 2.39M 2.16M 2.14M 2.14M 2.14M 2.13M 2.12M 2.12M 2.11M 2.11M 2.11M 2.11M 2.1M 2.1M
Retained Earnings
3.06B n/a 1.11B -134.63M -132.43M -130.56M -127.11M -121.93M -119.33M -116.23M -112.09M -103M -97.04M -90.24M -83.03M -75.84M -70.1M -60.19M -51.97M -47.23M -43.81M -40.7M
Comprehensive Income
1.1M 1.93B 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 1.1M 244K -1.81M
Shareholders Equity
3.9B 1.93B 1.93B 17.48M 19.05M 20.63M 23.59M 26.59M 28.56M 26.85M 30.08M 38.78M 44.34M 50.57M 56.84M 63.27M 68.49M 77.65M 85.04M 88.08M 90.21M 90.61M
Total Investments
407K n/a 4.24M 14.48M 17.62M 18.5M 20.73M 22.56M 23.41M 21.84M 26.82M 28.53M 32.89M 30.39M 299K 283K 42.33M 10.34M 72.93M 65.48M 77.99M 87.58M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.